| |
KO |
 09100 Metabolism
|
|
|
09120 Genetic Information Processing
|
|
|
09130 Environmental Information Processing
|
|
|
 09140 Cellular Processes
|
|
|
09141 Transport and catabolism
|
|
|
09143 Cell growth and death
|
04110 Cell cycle [PATH:hsa04110]
|
 04111 Cell cycle - yeast
|
04112 Cell cycle - Caulobacter
|
04113 Meiosis - yeast
|
04114 Oocyte meiosis [PATH:hsa04114]
|
04210 Apoptosis [PATH:hsa04210]
|
8743 TNFSF10; TNF superfamily member 10
8797 TNFRSF10A; TNF receptor superfamily member 10a
8795 TNFRSF10B; TNF receptor superfamily member 10b
356 FASLG; Fas ligand
355 FAS; Fas cell surface death receptor
8772 FADD; Fas associated via death domain
7124 TNF; tumor necrosis factor
7132 TNFRSF1A; TNF receptor superfamily member 1A
8717 TRADD; TNFRSF1A associated via death domain
8837 CFLAR; CASP8 and FADD like apoptosis regulator
841 CASP8; caspase 8
843 CASP10; caspase 10
839 CASP6; caspase 6
836 CASP3; caspase 3
840 CASP7; caspase 7
637 BID; BH3 interacting domain death agonist
581 BAX; BCL2 associated X, apoptosis regulator
578 BAK1; BCL2 antagonist/killer 1
56616 DIABLO; diablo IAP-binding mitochondrial protein
5414 SEPTIN4; septin 4
27429 HTRA2; HtrA serine peptidase 2
54205 CYCS; cytochrome c, somatic
317 APAF1; apoptotic peptidase activating factor 1
842 CASP9; caspase 9
5551 PRF1; perforin 1
3002 GZMB; granzyme B
10376 TUBA1B; tubulin alpha 1b
7277 TUBA4A; tubulin alpha 4a
7278 TUBA3C; tubulin alpha 3c
7846 TUBA1A; tubulin alpha 1a
84790 TUBA1C; tubulin alpha 1c
51807 TUBA8; tubulin alpha 8
112714 TUBA3E; tubulin alpha 3e
113457 TUBA3D; tubulin alpha 3d
79861 TUBAL3; tubulin alpha like 3
4170 MCL1; MCL1 apoptosis regulator, BCL2 family member
71 ACTG1; actin gamma 1
60 ACTB; actin beta
6708 SPTA1; spectrin alpha, erythrocytic 1
6709 SPTAN1; spectrin alpha, non-erythrocytic 1
4000 LMNA; lamin A/C
4001 LMNB1; lamin B1
84823 LMNB2; lamin B2
142 PARP1; poly(ADP-ribose) polymerase 1
10038 PARP2; poly(ADP-ribose) polymerase 2
10039 PARP3; poly(ADP-ribose) polymerase family member 3
143 PARP4; poly(ADP-ribose) polymerase family member 4
1676 DFFA; DNA fragmentation factor subunit alpha
1677 DFFB; DNA fragmentation factor subunit beta
2021 ENDOG; endonuclease G
9131 AIFM1; apoptosis inducing factor mitochondria associated 1
2081 ERN1; endoplasmic reticulum to nucleus signaling 1
7186 TRAF2; TNF receptor associated factor 2
3708 ITPR1; inositol 1,4,5-trisphosphate receptor type 1
3709 ITPR2; inositol 1,4,5-trisphosphate receptor type 2
3710 ITPR3; inositol 1,4,5-trisphosphate receptor type 3
823 CAPN1; calpain 1
824 CAPN2; calpain 2
100506742 CASP12; caspase 12 (gene/pseudogene)
9451 EIF2AK3; eukaryotic translation initiation factor 2 alpha kinase 3
1965 EIF2S1; eukaryotic translation initiation factor 2 subunit alpha
468 ATF4; activating transcription factor 4
1649 DDIT3; DNA damage inducible transcript 3
1508 CTSB; cathepsin B
1075 CTSC; cathepsin C
1509 CTSD; cathepsin D
8722 CTSF; cathepsin F
1512 CTSH; cathepsin H
1513 CTSK; cathepsin K
1514 CTSL; cathepsin L
1519 CTSO; cathepsin O
1520 CTSS; cathepsin S
1515 CTSV; cathepsin V
1521 CTSW; cathepsin W
1522 CTSZ; cathepsin Z
329 BIRC2; baculoviral IAP repeat containing 2
330 BIRC3; baculoviral IAP repeat containing 3
331 XIAP; X-linked inhibitor of apoptosis
332 BIRC5; baculoviral IAP repeat containing 5
10018 BCL2L11; BCL2 like 11
598 BCL2L1; BCL2 like 1
596 BCL2; BCL2 apoptosis regulator
1616 DAXX; death domain associated protein
8737 RIPK1; receptor interacting serine/threonine kinase 1
153090 DAB2IP; DAB2 interacting protein
4217 MAP3K5; mitogen-activated protein kinase kinase kinase 5
5599 MAPK8; mitogen-activated protein kinase 8
5602 MAPK10; mitogen-activated protein kinase 10
5601 MAPK9; mitogen-activated protein kinase 9
572 BAD; BCL2 associated agonist of cell death
3725 JUN; Jun proto-oncogene, AP-1 transcription factor subunit
2353 FOS; Fos proto-oncogene, AP-1 transcription factor subunit
7157 TP53; tumor protein p53
8739 HRK; harakiri, BCL2 interacting protein
9020 MAP3K14; mitogen-activated protein kinase kinase kinase 14
1147 CHUK; component of inhibitor of nuclear factor kappa B kinase complex
3551 IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta
8517 IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
4792 NFKBIA; NFKB inhibitor alpha
4790 NFKB1; nuclear factor kappa B subunit 1
5970 RELA; RELA proto-oncogene, NF-kB subunit
5783 PTPN13; protein tyrosine phosphatase non-receptor type 13
1647 GADD45A; growth arrest and DNA damage inducible alpha
4616 GADD45B; growth arrest and DNA damage inducible beta
10912 GADD45G; growth arrest and DNA damage inducible gamma
7185 TRAF1; TNF receptor associated factor 1
597 BCL2A1; BCL2 related protein A1
472 ATM; ATM serine/threonine kinase
55367 PIDD1; p53-induced death domain protein 1
63970 TP53AIP1; tumor protein p53 regulated apoptosis inducing protein 1
27113 BBC3; BCL2 binding component 3
5366 PMAIP1; phorbol-12-myristate-13-acetate-induced protein 1
835 CASP2; caspase 2
4803 NGF; nerve growth factor
4914 NTRK1; neurotrophic receptor tyrosine kinase 1
3562 IL3; interleukin 3
3563 IL3RA; interleukin 3 receptor subunit alpha
1439 CSF2RB; colony stimulating factor 2 receptor subunit beta
5290 PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
5293 PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
5291 PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
5295 PIK3R1; phosphoinositide-3-kinase regulatory subunit 1
5296 PIK3R2; phosphoinositide-3-kinase regulatory subunit 2
8503 PIK3R3; phosphoinositide-3-kinase regulatory subunit 3
5170 PDPK1; 3-phosphoinositide dependent protein kinase 1
207 AKT1; AKT serine/threonine kinase 1
208 AKT2; AKT serine/threonine kinase 2
10000 AKT3; AKT serine/threonine kinase 3
3265 HRAS; HRas proto-oncogene, GTPase
3845 KRAS; KRAS proto-oncogene, GTPase
4893 NRAS; NRAS proto-oncogene, GTPase
5894 RAF1; Raf-1 proto-oncogene, serine/threonine kinase
5604 MAP2K1; mitogen-activated protein kinase kinase 1
5605 MAP2K2; mitogen-activated protein kinase kinase 2
5594 MAPK1; mitogen-activated protein kinase 1
5595 MAPK3; mitogen-activated protein kinase 3
|
K04721 TNFSF10; tumor necrosis factor ligand superfamily member 10
K04722 TNFRSF10A_B; tumor necrosis factor receptor superfamily member 10A/B
K04722 TNFRSF10A_B; tumor necrosis factor receptor superfamily member 10A/B
K04389 TNFSF6; tumor necrosis factor ligand superfamily member 6
K04390 TNFRSF6; tumor necrosis factor receptor superfamily member 6
K02373 FADD; FAS-associated death domain protein
K03156 TNF; tumor necrosis factor superfamily, member 2
K03158 TNFRSF1A; tumor necrosis factor receptor superfamily member 1A
K03171 TRADD; tumor necrosis factor receptor type 1-associated DEATH domain protein
K04724 CFLAR; CASP8 and FADD-like apoptosis regulator
K04398 CASP8; caspase 8 [EC:3.4.22.61]
K04400 CASP10; caspase 10 [EC:3.4.22.63]
K04396 CASP6; caspase 6 [EC:3.4.22.59]
K02187 CASP3; caspase 3 [EC:3.4.22.56]
K04397 CASP7; caspase 7 [EC:3.4.22.60]
K04726 BID; BH3 interacting domain death agonist
K02159 BAX; apoptosis regulator BAX
K14021 BAK; Bcl-2 homologous antagonist/killer
K10522 DIABLO; diablo
K16943 SEPT4; septin 4
K08669 HTRA2; HtrA serine peptidase 2 [EC:3.4.21.108]
K08738 CYC; cytochrome c
K02084 APAF1; apoptotic protease-activating factor
K04399 CASP9; caspase 9 [EC:3.4.22.62]
K07818 PRF1; perforin 1
K01353 GZMB; granzyme B [EC:3.4.21.79]
K07374 TUBA; tubulin alpha
K07374 TUBA; tubulin alpha
K07374 TUBA; tubulin alpha
K07374 TUBA; tubulin alpha
K07374 TUBA; tubulin alpha
K07374 TUBA; tubulin alpha
K07374 TUBA; tubulin alpha
K07374 TUBA; tubulin alpha
K07374 TUBA; tubulin alpha
K02539 MCL1; myeloid leukemia cell differntiation protein MCL-1
K05692 ACTB_G1; actin beta/gamma 1
K05692 ACTB_G1; actin beta/gamma 1
K06114 SPTA; spectrin alpha
K06114 SPTA; spectrin alpha
K12641 LMNA; lamin A/C
K07611 LMNB; lamin B
K07611 LMNB; lamin B
K24070 PARP1; poly [ADP-ribose] polymerase 1 [EC:2.4.2.30]
K10798 PARP2_3_4; poly [ADP-ribose] polymerase 2/3/4 [EC:2.4.2.30]
K10798 PARP2_3_4; poly [ADP-ribose] polymerase 2/3/4 [EC:2.4.2.30]
K10798 PARP2_3_4; poly [ADP-ribose] polymerase 2/3/4 [EC:2.4.2.30]
K02310 DFFA; DNA fragmentation factor, 45 kD, alpha subunit
K02311 DFFB; DNA fragmentation factor, 40 kD, beta subunit [EC:3.-.-.-]
K01173 ENDOG; endonuclease G, mitochondrial
K04727 AIFM1; apoptosis-inducing factor 1 [EC:1.-.-.-]
K08852 ERN1; serine/threonine-protein kinase/endoribonuclease IRE1 [EC:2.7.11.1 3.1.26.-]
K03173 TRAF2; TNF receptor-associated factor 2 [EC:2.3.2.27]
K04958 ITPR1; inositol 1,4,5-triphosphate receptor type 1
K04959 ITPR2; inositol 1,4,5-triphosphate receptor type 2
K04960 ITPR3; inositol 1,4,5-triphosphate receptor type 3
K01367 CAPN1; calpain-1 [EC:3.4.22.52]
K03853 CAPN2; calpain-2 [EC:3.4.22.53]
K04741 CASP12; caspase 12 [EC:3.4.22.-]
K08860 EIF2AK3; eukaryotic translation initiation factor 2-alpha kinase 3 [EC:2.7.11.1]
K03237 EIF2S1; translation initiation factor 2 subunit 1
K04374 ATF4; cyclic AMP-dependent transcription factor ATF-4
K04452 DDIT3; DNA damage-inducible transcript 3
K01363 CTSB; cathepsin B [EC:3.4.22.1]
K01275 CTSC; cathepsin C [EC:3.4.14.1]
K01379 CTSD; cathepsin D [EC:3.4.23.5]
K01373 CTSF; cathepsin F [EC:3.4.22.41]
K01366 CTSH; cathepsin H [EC:3.4.22.16]
K01371 CTSK; cathepsin K [EC:3.4.22.38]
K01365 CTSL; cathepsin L [EC:3.4.22.15]
K01374 CTSO; cathepsin O [EC:3.4.22.42]
K01368 CTSS; cathepsin S [EC:3.4.22.27]
K01375 CTSL2; cathepsin V [EC:3.4.22.43]
K08569 CTSW; cathepsin W [EC:3.4.22.-]
K08568 CTSZ; cathepsin X [EC:3.4.18.1]
K16060 BIRC2_3; baculoviral IAP repeat-containing protein 2/3
K16060 BIRC2_3; baculoviral IAP repeat-containing protein 2/3
K04725 XIAP; E3 ubiquitin-protein ligase XIAP [EC:2.3.2.27]
K08731 BIRC5; baculoviral IAP repeat-containing protein 5
K16341 BCL2L11; Bcl-2-like protein 11
K04570 BCL2L1; Bcl-2-like 1 (apoptosis regulator Bcl-X)
K02161 BCL2; apoptosis regulator Bcl-2
K02308 DAXX; death-associated protein 6
K02861 RIPK1; receptor-interacting serine/threonine-protein kinase 1 [EC:2.7.11.1]
K19901 DAB2IP; disabled homolog 2-interacting protein
K04426 MAP3K5; mitogen-activated protein kinase kinase kinase 5 [EC:2.7.11.25]
K04440 JNK; mitogen-activated protein kinase 8/9/10 (c-Jun N-terminal kinase) [EC:2.7.11.24]
K04440 JNK; mitogen-activated protein kinase 8/9/10 (c-Jun N-terminal kinase) [EC:2.7.11.24]
K04440 JNK; mitogen-activated protein kinase 8/9/10 (c-Jun N-terminal kinase) [EC:2.7.11.24]
K02158 BAD; Bcl-2-antagonist of cell death
K04448 JUN; transcription factor AP-1
K04379 FOS; proto-oncogene protein c-fos
K04451 TP53; tumor protein p53
K02512 HRK; activator of apoptosis harakiri
K04466 MAP3K14; mitogen-activated protein kinase kinase kinase 14 [EC:2.7.11.25]
K04467 IKBKA; inhibitor of nuclear factor kappa-B kinase subunit alpha [EC:2.7.11.10]
K07209 IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta [EC:2.7.11.10]
K07210 IKBKG; inhibitor of nuclear factor kappa-B kinase subunit gamma
K04734 NFKBIA; NF-kappa-B inhibitor alpha
K02580 NFKB1; nuclear factor NF-kappa-B p105 subunit
K04735 RELA; transcription factor p65
K02374 PTPN13; tyrosine-protein phosphatase non-receptor type 13
K04402 GADD45; growth arrest and DNA-damage-inducible protein
K04402 GADD45; growth arrest and DNA-damage-inducible protein
K04402 GADD45; growth arrest and DNA-damage-inducible protein
K03172 TRAF1; TNF receptor-associated factor 1
K02162 BCL2A1; hematopoietic Bcl-2-related protein A1
K04728 ATM; serine-protein kinase ATM [EC:2.7.11.1]
K10130 LRDD; leucine-rich repeats and death domain-containing protein
K13773 TP53AIP1; p53-regulated apoptosis-inducing protein 1
K10132 BBC3; Bcl-2-binding component 3
K10131 PMAIP1; phorbol-12-myristate-13-acetate-induced protein 1
K02186 CASP2; caspase 2 [EC:3.4.22.55]
K02582 NGFB; nerve growth factor, beta
K03176 NTRK1; neurotrophic tyrosine kinase receptor type 1 [EC:2.7.10.1]
K04736 IL3; interleukin 3
K04737 IL3RA; interleukin 3 receptor alpha
K04738 CSF2RB; cytokine receptor common subunit beta
K00922 PIK3CA_B_D; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta [EC:2.7.1.153]
K00922 PIK3CA_B_D; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta [EC:2.7.1.153]
K00922 PIK3CA_B_D; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta [EC:2.7.1.153]
K02649 PIK3R1_2_3; phosphoinositide-3-kinase regulatory subunit alpha/beta/delta
K02649 PIK3R1_2_3; phosphoinositide-3-kinase regulatory subunit alpha/beta/delta
K02649 PIK3R1_2_3; phosphoinositide-3-kinase regulatory subunit alpha/beta/delta
K06276 PDPK1; 3-phosphoinositide dependent protein kinase-1 [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K02833 HRAS; GTPase HRas
K07827 KRAS; GTPase KRas
K07828 NRAS; GTPase NRas
K04366 RAF1; RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K04368 MAP2K1; mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
K04369 MAP2K2; mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
K04371 ERK; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04371 ERK; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
|
04214 Apoptosis - fly
|
04215 Apoptosis - multiple species [PATH:hsa04215]
|
04216 Ferroptosis [PATH:hsa04216]
|
04217 Necroptosis [PATH:hsa04217]
|
04115 p53 signaling pathway [PATH:hsa04115]
|
04218 Cellular senescence [PATH:hsa04218]
|
|
|
09144 Cellular community - eukaryotes
|
|
|
09145 Cellular community - prokaryotes
|
|
|
09142 Cell motility
|
|
|
09150 Organismal Systems
|
|
|
09151 Immune system
|
04640 Hematopoietic cell lineage [PATH:hsa04640]
|
04610 Complement and coagulation cascades [PATH:hsa04610]
|
04611 Platelet activation [PATH:hsa04611]
|
04613 Neutrophil extracellular trap formation [PATH:hsa04613]
|
04620 Toll-like receptor signaling pathway [PATH:hsa04620]
|
04624 Toll and Imd signaling pathway
|
04621 NOD-like receptor signaling pathway [PATH:hsa04621]
|
04622 RIG-I-like receptor signaling pathway [PATH:hsa04622]
|
04623 Cytosolic DNA-sensing pathway [PATH:hsa04623]
|
04625 C-type lectin receptor signaling pathway [PATH:hsa04625]
|
04650 Natural killer cell mediated cytotoxicity [PATH:hsa04650]
|
3105 HLA-A; major histocompatibility complex, class I, A
3106 HLA-B; major histocompatibility complex, class I, B
3107 HLA-C; major histocompatibility complex, class I, C
3134 HLA-F; major histocompatibility complex, class I, F
3135 HLA-G; major histocompatibility complex, class I, G
3133 HLA-E; major histocompatibility complex, class I, E
3812 KIR3DL2; killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2
3811 KIR3DL1; killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1
115653 KIR3DL3; killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 3
3803 KIR2DL2; killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 2
3802 KIR2DL1; killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1
3804 KIR2DL3; killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 3
57292 KIR2DL5A; killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 5A
3821 KLRC1; killer cell lectin like receptor C1
3824 KLRD1; killer cell lectin like receptor D1
5777 PTPN6; protein tyrosine phosphatase non-receptor type 6
5781 PTPN11; protein tyrosine phosphatase non-receptor type 11
3383 ICAM1; intercellular adhesion molecule 1
3384 ICAM2; intercellular adhesion molecule 2
3683 ITGAL; integrin subunit alpha L
3689 ITGB2; integrin subunit beta 2
2185 PTK2B; protein tyrosine kinase 2 beta
10451 VAV3; vav guanine nucleotide exchange factor 3
7409 VAV1; vav guanine nucleotide exchange factor 1
7410 VAV2; vav guanine nucleotide exchange factor 2
5879 RAC1; Rac family small GTPase 1
5880 RAC2; Rac family small GTPase 2
5881 RAC3; Rac family small GTPase 3
5058 PAK1; p21 (RAC1) activated kinase 1
5604 MAP2K1; mitogen-activated protein kinase kinase 1
5605 MAP2K2; mitogen-activated protein kinase kinase 2
5594 MAPK1; mitogen-activated protein kinase 1
5595 MAPK3; mitogen-activated protein kinase 3
7124 TNF; tumor necrosis factor
1437 CSF2; colony stimulating factor 2
3458 IFNG; interferon gamma
3806 KIR2DS1; killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 1
3808 KIR2DS3; killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 3
3809 KIR2DS4; killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 4
3810 KIR2DS5; killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 5
100132285 KIR2DS2; killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 2
3822 KLRC2; killer cell lectin like receptor C2
3823 KLRC3; killer cell lectin like receptor C3
9436 NCR2; natural cytotoxicity triggering receptor 2
7305 TYROBP; transmembrane immune signaling adaptor TYROBP
3932 LCK; LCK proto-oncogene, Src family tyrosine kinase
102723407 IGH; immunoglobulin heavy variable 4-38-2-like
2214 FCGR3A; Fc fragment of IgG receptor IIIa
2215 FCGR3B; Fc fragment of IgG receptor IIIb
9437 NCR1; natural cytotoxicity triggering receptor 1
259197 NCR3; natural cytotoxicity triggering receptor 3
2207 FCER1G; Fc fragment of IgE receptor Ig
919 CD247; CD247 molecule
7535 ZAP70; zeta chain of T cell receptor associated protein kinase 70
6850 SYK; spleen associated tyrosine kinase
3937 LCP2; lymphocyte cytosolic protein 2
27040 LAT; linker for activation of T cells
5335 PLCG1; phospholipase C gamma 1
5336 PLCG2; phospholipase C gamma 2
6452 SH3BP2; SH3 domain binding protein 2
5290 PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
5293 PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
5291 PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
5295 PIK3R1; phosphoinositide-3-kinase regulatory subunit 1
5296 PIK3R2; phosphoinositide-3-kinase regulatory subunit 2
8503 PIK3R3; phosphoinositide-3-kinase regulatory subunit 3
2534 FYN; FYN proto-oncogene, Src family tyrosine kinase
6464 SHC1; SHC adaptor protein 1
25759 SHC2; SHC adaptor protein 2
53358 SHC3; SHC adaptor protein 3
399694 SHC4; SHC adaptor protein 4
2885 GRB2; growth factor receptor bound protein 2
6654 SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1
6655 SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2
3265 HRAS; HRas proto-oncogene, GTPase
3845 KRAS; KRAS proto-oncogene, GTPase
4893 NRAS; NRAS proto-oncogene, GTPase
369 ARAF; A-Raf proto-oncogene, serine/threonine kinase
673 BRAF; B-Raf proto-oncogene, serine/threonine kinase
5894 RAF1; Raf-1 proto-oncogene, serine/threonine kinase
4277 MICB; MHC class I polypeptide-related sequence B
100507436 MICA; MHC class I polypeptide-related sequence A
80329 ULBP1; UL16 binding protein 1
80328 ULBP2; UL16 binding protein 2
79465 ULBP3; UL16 binding protein 3
22914 KLRK1; killer cell lectin like receptor K1
100528032 KLRC4-KLRK1; KLRC4-KLRK1 readthrough
10870 HCST; hematopoietic cell signal transducer
962 CD48; CD48 molecule
51744 CD244; CD244 molecule
5530 PPP3CA; protein phosphatase 3 catalytic subunit alpha
5532 PPP3CB; protein phosphatase 3 catalytic subunit beta
5533 PPP3CC; protein phosphatase 3 catalytic subunit gamma
5534 PPP3R1; protein phosphatase 3 regulatory subunit B, alpha
5535 PPP3R2; protein phosphatase 3 regulatory subunit B, beta
4772 NFATC1; nuclear factor of activated T cells 1
4773 NFATC2; nuclear factor of activated T cells 2
5578 PRKCA; protein kinase C alpha
5579 PRKCB; protein kinase C beta
5582 PRKCG; protein kinase C gamma
117157 SH2D1B; SH2 domain containing 1B
4068 SH2D1A; SH2 domain containing 1A
3459 IFNGR1; interferon gamma receptor 1
3460 IFNGR2; interferon gamma receptor 2
3439 IFNA1; interferon alpha 1
3440 IFNA2; interferon alpha 2
3441 IFNA4; interferon alpha 4
3442 IFNA5; interferon alpha 5
3443 IFNA6; interferon alpha 6
3444 IFNA7; interferon alpha 7
3445 IFNA8; interferon alpha 8
3446 IFNA10; interferon alpha 10
3447 IFNA13; interferon alpha 13
3448 IFNA14; interferon alpha 14
3449 IFNA16; interferon alpha 16
3451 IFNA17; interferon alpha 17
3452 IFNA21; interferon alpha 21
3456 IFNB1; interferon beta 1
3454 IFNAR1; interferon alpha and beta receptor subunit 1
3455 IFNAR2; interferon alpha and beta receptor subunit 2
8743 TNFSF10; TNF superfamily member 10
8797 TNFRSF10A; TNF receptor superfamily member 10a
8795 TNFRSF10B; TNF receptor superfamily member 10b
356 FASLG; Fas ligand
355 FAS; Fas cell surface death receptor
3002 GZMB; granzyme B
5551 PRF1; perforin 1
836 CASP3; caspase 3
637 BID; BH3 interacting domain death agonist
353091 RAET1G; retinoic acid early transcript 1G
154064 RAET1L; retinoic acid early transcript 1L
135250 RAET1E; retinoic acid early transcript 1E
|
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K07980 KIR3DL; killer cell immunoglobulin-like receptor 3DL
K07980 KIR3DL; killer cell immunoglobulin-like receptor 3DL
K07980 KIR3DL; killer cell immunoglobulin-like receptor 3DL
K07981 KIR2DL1_2_3; killer cell immunoglobulin-like receptor 2DL1/2/3
K07981 KIR2DL1_2_3; killer cell immunoglobulin-like receptor 2DL1/2/3
K07981 KIR2DL1_2_3; killer cell immunoglobulin-like receptor 2DL1/2/3
K24232 KIR2DL5; killer cell immunoglobulin-like receptor 2DL5
K06541 KLRC1; killer cell lectin-like receptor subfamily C1
K06516 KLRD1; killer cell lectin-like receptor subfamily D member 1
K05697 PTPN6; tyrosine-protein phosphatase non-receptor type 6 [EC:3.1.3.48]
K07293 PTPN11; tyrosine-protein phosphatase non-receptor type 11 [EC:3.1.3.48]
K06490 ICAM1; intercellular adhesion molecule 1
K06523 ICAM2; intercellular adhesion molecule 2
K05718 ITGAL; integrin alpha L
K06464 ITGB2; integrin beta 2
K05871 PTK2B; focal adhesion kinase 2 [EC:2.7.10.2]
K05730 VAV; guanine nucleotide exchange factor VAV
K05730 VAV; guanine nucleotide exchange factor VAV
K05730 VAV; guanine nucleotide exchange factor VAV
K04392 RAC1; Ras-related C3 botulinum toxin substrate 1
K07860 RAC2; Ras-related C3 botulinum toxin substrate 2
K07861 RAC3; Ras-related C3 botulinum toxin substrate 3
K04409 PAK1; p21-activated kinase 1 [EC:2.7.11.1]
K04368 MAP2K1; mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
K04369 MAP2K2; mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
K04371 ERK; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04371 ERK; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K03156 TNF; tumor necrosis factor superfamily, member 2
K05427 CSF2; granulocyte-macrophage colony-stimulating factor
K04687 IFNG; interferon gamma
K07982 KIR2DS; killer cell immunoglobulin-like receptor 2DS
K07982 KIR2DS; killer cell immunoglobulin-like receptor 2DS
K07982 KIR2DS; killer cell immunoglobulin-like receptor 2DS
K07982 KIR2DS; killer cell immunoglobulin-like receptor 2DS
K07982 KIR2DS; killer cell immunoglobulin-like receptor 2DS
K24233 KLRC2_3; killer cell lectin-like receptor subfamily C2/3
K24233 KLRC2_3; killer cell lectin-like receptor subfamily C2/3
K06742 NCR2; natural cytotoxicity triggering receptor 2
K07992 TYROBP; TYRO protein tyrosine kinase binding protein
K05856 LCK; lymphocyte cell-specific protein tyrosine kinase [EC:2.7.10.2]
K06856 IGH; immunoglobulin heavy chain
K06463 FCGR3; low affinity immunoglobulin gamma Fc receptor III
K06463 FCGR3; low affinity immunoglobulin gamma Fc receptor III
K06741 NCR1; natural cytotoxicity triggering receptor 1
K06743 NCR3; natural cytotoxicity triggering receptor 3
K07983 FCER1G; high affinity immunoglobulin epsilon receptor subunit gamma
K06453 CD3Z; CD3Z antigen, zeta polypeptide
K07360 ZAP70; tyrosine-protein kinase ZAP-70 [EC:2.7.10.2]
K05855 SYK; spleen tyrosine kinase [EC:2.7.10.2]
K07361 LCP2; lymphocyte cytosolic protein 2
K07362 LAT; linker for activation of T cells
K01116 PLCG1; phosphatidylinositol phospholipase C, gamma-1 [EC:3.1.4.11]
K05859 PLCG2; phosphatidylinositol phospholipase C, gamma-2 [EC:3.1.4.11]
K07984 SH3BP2; SH3-domain binding protein 2
K00922 PIK3CA_B_D; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta [EC:2.7.1.153]
K00922 PIK3CA_B_D; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta [EC:2.7.1.153]
K00922 PIK3CA_B_D; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta [EC:2.7.1.153]
K02649 PIK3R1_2_3; phosphoinositide-3-kinase regulatory subunit alpha/beta/delta
K02649 PIK3R1_2_3; phosphoinositide-3-kinase regulatory subunit alpha/beta/delta
K02649 PIK3R1_2_3; phosphoinositide-3-kinase regulatory subunit alpha/beta/delta
K05703 FYN; tyrosine-protein kinase Fyn [EC:2.7.10.2]
K06279 SHC1; SHC-transforming protein 1
K17447 SHC2; SHC-transforming protein 2
K17448 SHC3; SHC-transforming protein 3
K17449 SHC4; SHC-transforming protein 4
K04364 GRB2; growth factor receptor-bound protein 2
K03099 SOS; son of sevenless
K03099 SOS; son of sevenless
K02833 HRAS; GTPase HRas
K07827 KRAS; GTPase KRas
K07828 NRAS; GTPase NRas
K08845 ARAF; A-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K04365 BRAF; B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K04366 RAF1; RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K07985 MIC; MHC class I-related protein
K07985 MIC; MHC class I-related protein
K07986 ULBP; UL16 binding protein
K07986 ULBP; UL16 binding protein
K07986 ULBP; UL16 binding protein
K06728 KLRK1; killer cell lectin-like receptor subfamily K member 1
K06728 KLRK1; killer cell lectin-like receptor subfamily K member 1
K07988 HCST; hematopoietic cell signal transducer
K06479 CD48; CD48 antigen
K06582 CD244; natural killer cell receptor 2B4
K04348 PPP3C; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
K04348 PPP3C; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
K04348 PPP3C; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
K06268 PPP3R; serine/threonine-protein phosphatase 2B regulatory subunit
K06268 PPP3R; serine/threonine-protein phosphatase 2B regulatory subunit
K04446 NFATC1; nuclear factor of activated T-cells, cytoplasmic 1
K17332 NFATC2; nuclear factor of activated T-cells, cytoplasmic 2
K02677 PRKCA; classical protein kinase C alpha type [EC:2.7.11.13]
K19662 PRKCB; classical protein kinase C beta type [EC:2.7.11.13]
K19663 PRKCG; classical protein kinase C gamma type [EC:2.7.11.13]
K07989 SH2D1B; SH2 domain-containing protein 1B
K07990 SH2D1A; SH2 domain-containing protein 1A
K05132 IFNGR1; interferon gamma receptor 1
K05133 IFNGR2; interferon gamma receptor 2
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05415 IFNB; interferon beta
K05130 IFNAR1; interferon receptor 1
K05131 IFNAR2; interferon receptor 2
K04721 TNFSF10; tumor necrosis factor ligand superfamily member 10
K04722 TNFRSF10A_B; tumor necrosis factor receptor superfamily member 10A/B
K04722 TNFRSF10A_B; tumor necrosis factor receptor superfamily member 10A/B
K04389 TNFSF6; tumor necrosis factor ligand superfamily member 6
K04390 TNFRSF6; tumor necrosis factor receptor superfamily member 6
K01353 GZMB; granzyme B [EC:3.4.21.79]
K07818 PRF1; perforin 1
K02187 CASP3; caspase 3 [EC:3.4.22.56]
K04726 BID; BH3 interacting domain death agonist
K07987 RAET1; retinoic acid early transcript 1
K07987 RAET1; retinoic acid early transcript 1
K07987 RAET1; retinoic acid early transcript 1
|
04612 Antigen processing and presentation [PATH:hsa04612]
|
04660 T cell receptor signaling pathway [PATH:hsa04660]
|
04658 Th1 and Th2 cell differentiation [PATH:hsa04658]
|
04659 Th17 cell differentiation [PATH:hsa04659]
|
04657 IL-17 signaling pathway [PATH:hsa04657]
|
04662 B cell receptor signaling pathway [PATH:hsa04662]
|
04664 Fc epsilon RI signaling pathway [PATH:hsa04664]
|
04666 Fc gamma R-mediated phagocytosis [PATH:hsa04666]
|
04670 Leukocyte transendothelial migration [PATH:hsa04670]
|
04672 Intestinal immune network for IgA production [PATH:hsa04672]
|
04062 Chemokine signaling pathway [PATH:hsa04062]
|
|
|
09152 Endocrine system
|
|
|
09153 Circulatory system
|
|
|
09154 Digestive system
|
|
|
09155 Excretory system
|
|
|
09156 Nervous system
|
|
|
09157 Sensory system
|
|
|
09158 Development and regeneration
|
|
|
09149 Aging
|
|
|
09159 Environmental adaptation
|
|
|
09160 Human Diseases
|
|
|
09161 Cancer: overview
|
|
|
09162 Cancer: specific types
|
|
|
09163 Immune disease
|
05310 Asthma [PATH:hsa05310]
|
05322 Systemic lupus erythematosus [PATH:hsa05322]
|
05323 Rheumatoid arthritis [PATH:hsa05323]
|
05320 Autoimmune thyroid disease [PATH:hsa05320]
|
3439 IFNA1; interferon alpha 1
3440 IFNA2; interferon alpha 2
3441 IFNA4; interferon alpha 4
3442 IFNA5; interferon alpha 5
3443 IFNA6; interferon alpha 6
3444 IFNA7; interferon alpha 7
3445 IFNA8; interferon alpha 8
3446 IFNA10; interferon alpha 10
3447 IFNA13; interferon alpha 13
3448 IFNA14; interferon alpha 14
3449 IFNA16; interferon alpha 16
3451 IFNA17; interferon alpha 17
3452 IFNA21; interferon alpha 21
3108 HLA-DMA; major histocompatibility complex, class II, DM alpha
3109 HLA-DMB; major histocompatibility complex, class II, DM beta
3111 HLA-DOA; major histocompatibility complex, class II, DO alpha
3112 HLA-DOB; major histocompatibility complex, class II, DO beta
3113 HLA-DPA1; major histocompatibility complex, class II, DP alpha 1
3115 HLA-DPB1; major histocompatibility complex, class II, DP beta 1
3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1
3118 HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2
3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1
3122 HLA-DRA; major histocompatibility complex, class II, DR alpha
3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1
3125 HLA-DRB3; major histocompatibility complex, class II, DR beta 3
3126 HLA-DRB4; major histocompatibility complex, class II, DR beta 4
3127 HLA-DRB5; major histocompatibility complex, class II, DR beta 5
1493 CTLA4; cytotoxic T-lymphocyte associated protein 4
7173 TPO; thyroid peroxidase
7038 TG; thyroglobulin
941 CD80; CD80 molecule
942 CD86; CD86 molecule
940 CD28; CD28 molecule
3558 IL2; interleukin 2
3105 HLA-A; major histocompatibility complex, class I, A
3106 HLA-B; major histocompatibility complex, class I, B
3107 HLA-C; major histocompatibility complex, class I, C
3134 HLA-F; major histocompatibility complex, class I, F
3135 HLA-G; major histocompatibility complex, class I, G
3133 HLA-E; major histocompatibility complex, class I, E
356 FASLG; Fas ligand
355 FAS; Fas cell surface death receptor
5551 PRF1; perforin 1
3002 GZMB; granzyme B
959 CD40LG; CD40 ligand
958 CD40; CD40 molecule
3565 IL4; interleukin 4
3567 IL5; interleukin 5
3586 IL10; interleukin 10
102723407 IGH; immunoglobulin heavy variable 4-38-2-like
7253 TSHR; thyroid stimulating hormone receptor
1081 CGA; glycoprotein hormones, alpha polypeptide
7252 TSHB; thyroid stimulating hormone subunit beta
|
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06538 CTLA4; cytotoxic T-lymphocyte-associated protein 4
K00431 TPO; thyroid peroxidase [EC:1.11.1.8]
K10809 TG; thyroglobulin
K05412 CD80; CD80 antigen
K05413 CD86; CD86 antigen
K06470 CD28; CD28 antigen
K05429 IL2; interleukin 2
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K04389 TNFSF6; tumor necrosis factor ligand superfamily member 6
K04390 TNFRSF6; tumor necrosis factor receptor superfamily member 6
K07818 PRF1; perforin 1
K01353 GZMB; granzyme B [EC:3.4.21.79]
K03161 TNFSF5; tumor necrosis factor ligand superfamily member 5
K03160 TNFRSF5; tumor necrosis factor receptor superfamily member 5
K05430 IL4; interleukin 4
K05428 IL5; interleukin 5
K05443 IL10; interleukin 10
K06856 IGH; immunoglobulin heavy chain
K04249 TSHR; thyrotropin receptor
K08522 CGA; glycoprotein hormones alpha chain
K05251 TSHB; thyrotropin subunit beta
|
05321 Inflammatory bowel disease [PATH:hsa05321]
|
05330 Allograft rejection [PATH:hsa05330]
|
3105 HLA-A; major histocompatibility complex, class I, A
3106 HLA-B; major histocompatibility complex, class I, B
3107 HLA-C; major histocompatibility complex, class I, C
3134 HLA-F; major histocompatibility complex, class I, F
3135 HLA-G; major histocompatibility complex, class I, G
3133 HLA-E; major histocompatibility complex, class I, E
941 CD80; CD80 molecule
942 CD86; CD86 molecule
940 CD28; CD28 molecule
3592 IL12A; interleukin 12A
3593 IL12B; interleukin 12B
356 FASLG; Fas ligand
355 FAS; Fas cell surface death receptor
5551 PRF1; perforin 1
3002 GZMB; granzyme B
3108 HLA-DMA; major histocompatibility complex, class II, DM alpha
3109 HLA-DMB; major histocompatibility complex, class II, DM beta
3111 HLA-DOA; major histocompatibility complex, class II, DO alpha
3112 HLA-DOB; major histocompatibility complex, class II, DO beta
3113 HLA-DPA1; major histocompatibility complex, class II, DP alpha 1
3115 HLA-DPB1; major histocompatibility complex, class II, DP beta 1
3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1
3118 HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2
3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1
3122 HLA-DRA; major histocompatibility complex, class II, DR alpha
3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1
3125 HLA-DRB3; major histocompatibility complex, class II, DR beta 3
3126 HLA-DRB4; major histocompatibility complex, class II, DR beta 4
3127 HLA-DRB5; major histocompatibility complex, class II, DR beta 5
3558 IL2; interleukin 2
959 CD40LG; CD40 ligand
958 CD40; CD40 molecule
3458 IFNG; interferon gamma
7124 TNF; tumor necrosis factor
3565 IL4; interleukin 4
3567 IL5; interleukin 5
3586 IL10; interleukin 10
102723407 IGH; immunoglobulin heavy variable 4-38-2-like
|
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K05412 CD80; CD80 antigen
K05413 CD86; CD86 antigen
K06470 CD28; CD28 antigen
K05406 IL12A; interleukin 12A
K05425 IL12B; interleukin 12B
K04389 TNFSF6; tumor necrosis factor ligand superfamily member 6
K04390 TNFRSF6; tumor necrosis factor receptor superfamily member 6
K07818 PRF1; perforin 1
K01353 GZMB; granzyme B [EC:3.4.21.79]
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K05429 IL2; interleukin 2
K03161 TNFSF5; tumor necrosis factor ligand superfamily member 5
K03160 TNFRSF5; tumor necrosis factor receptor superfamily member 5
K04687 IFNG; interferon gamma
K03156 TNF; tumor necrosis factor superfamily, member 2
K05430 IL4; interleukin 4
K05428 IL5; interleukin 5
K05443 IL10; interleukin 10
K06856 IGH; immunoglobulin heavy chain
|
05332 Graft-versus-host disease [PATH:hsa05332]
|
3569 IL6; interleukin 6
3552 IL1A; interleukin 1 alpha
3553 IL1B; interleukin 1 beta
7124 TNF; tumor necrosis factor
3108 HLA-DMA; major histocompatibility complex, class II, DM alpha
3109 HLA-DMB; major histocompatibility complex, class II, DM beta
3111 HLA-DOA; major histocompatibility complex, class II, DO alpha
3112 HLA-DOB; major histocompatibility complex, class II, DO beta
3113 HLA-DPA1; major histocompatibility complex, class II, DP alpha 1
3115 HLA-DPB1; major histocompatibility complex, class II, DP beta 1
3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1
3118 HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2
3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1
3122 HLA-DRA; major histocompatibility complex, class II, DR alpha
3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1
3125 HLA-DRB3; major histocompatibility complex, class II, DR beta 3
3126 HLA-DRB4; major histocompatibility complex, class II, DR beta 4
3127 HLA-DRB5; major histocompatibility complex, class II, DR beta 5
941 CD80; CD80 molecule
942 CD86; CD86 molecule
940 CD28; CD28 molecule
3558 IL2; interleukin 2
3105 HLA-A; major histocompatibility complex, class I, A
3106 HLA-B; major histocompatibility complex, class I, B
3107 HLA-C; major histocompatibility complex, class I, C
3134 HLA-F; major histocompatibility complex, class I, F
3135 HLA-G; major histocompatibility complex, class I, G
3133 HLA-E; major histocompatibility complex, class I, E
356 FASLG; Fas ligand
355 FAS; Fas cell surface death receptor
5551 PRF1; perforin 1
3002 GZMB; granzyme B
3458 IFNG; interferon gamma
3803 KIR2DL2; killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 2
3802 KIR2DL1; killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1
3804 KIR2DL3; killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 3
57292 KIR2DL5A; killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 5A
3812 KIR3DL2; killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2
3811 KIR3DL1; killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1
115653 KIR3DL3; killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 3
3821 KLRC1; killer cell lectin like receptor C1
3824 KLRD1; killer cell lectin like receptor D1
|
K05405 IL6; interleukin 6
K04383 IL1A; interleukin 1 alpha
K04519 IL1B; interleukin 1 beta
K03156 TNF; tumor necrosis factor superfamily, member 2
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K05412 CD80; CD80 antigen
K05413 CD86; CD86 antigen
K06470 CD28; CD28 antigen
K05429 IL2; interleukin 2
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K04389 TNFSF6; tumor necrosis factor ligand superfamily member 6
K04390 TNFRSF6; tumor necrosis factor receptor superfamily member 6
K07818 PRF1; perforin 1
K01353 GZMB; granzyme B [EC:3.4.21.79]
K04687 IFNG; interferon gamma
K07981 KIR2DL1_2_3; killer cell immunoglobulin-like receptor 2DL1/2/3
K07981 KIR2DL1_2_3; killer cell immunoglobulin-like receptor 2DL1/2/3
K07981 KIR2DL1_2_3; killer cell immunoglobulin-like receptor 2DL1/2/3
K24232 KIR2DL5; killer cell immunoglobulin-like receptor 2DL5
K07980 KIR3DL; killer cell immunoglobulin-like receptor 3DL
K07980 KIR3DL; killer cell immunoglobulin-like receptor 3DL
K07980 KIR3DL; killer cell immunoglobulin-like receptor 3DL
K06541 KLRC1; killer cell lectin-like receptor subfamily C1
K06516 KLRD1; killer cell lectin-like receptor subfamily D member 1
|
05340 Primary immunodeficiency [PATH:hsa05340]
|
|
|
09164 Neurodegenerative disease
|
|
|
09165 Substance dependence
|
|
|
09166 Cardiovascular disease
|
05418 Fluid shear stress and atherosclerosis [PATH:hsa05418]
|
05410 Hypertrophic cardiomyopathy [PATH:hsa05410]
|
05412 Arrhythmogenic right ventricular cardiomyopathy [PATH:hsa05412]
|
05414 Dilated cardiomyopathy [PATH:hsa05414]
|
05416 Viral myocarditis [PATH:hsa05416]
|
1525 CXADR; CXADR Ig-like cell adhesion molecule
1604 CD55; CD55 molecule (Cromer blood group)
2534 FYN; FYN proto-oncogene, Src family tyrosine kinase
857 CAV1; caveolin 1
25 ABL1; ABL proto-oncogene 1, non-receptor tyrosine kinase
27 ABL2; ABL proto-oncogene 2, non-receptor tyrosine kinase
5879 RAC1; Rac family small GTPase 1
5880 RAC2; Rac family small GTPase 2
5881 RAC3; Rac family small GTPase 3
6444 SGCD; sarcoglycan delta
6445 SGCG; sarcoglycan gamma
6442 SGCA; sarcoglycan alpha
6443 SGCB; sarcoglycan beta
284217 LAMA1; laminin subunit alpha 1
3908 LAMA2; laminin subunit alpha 2
1605 DAG1; dystroglycan 1
1756 DMD; dystrophin
71 ACTG1; actin gamma 1
60 ACTB; actin beta
8672 EIF4G3; eukaryotic translation initiation factor 4 gamma 3
1981 EIF4G1; eukaryotic translation initiation factor 4 gamma 1
1982 EIF4G2; eukaryotic translation initiation factor 4 gamma 2
595 CCND1; cyclin D1
841 CASP8; caspase 8
637 BID; BH3 interacting domain death agonist
54205 CYCS; cytochrome c, somatic
842 CASP9; caspase 9
836 CASP3; caspase 3
4625 MYH7; myosin heavy chain 7
4624 MYH6; myosin heavy chain 6
959 CD40LG; CD40 ligand
958 CD40; CD40 molecule
3108 HLA-DMA; major histocompatibility complex, class II, DM alpha
3109 HLA-DMB; major histocompatibility complex, class II, DM beta
3111 HLA-DOA; major histocompatibility complex, class II, DO alpha
3112 HLA-DOB; major histocompatibility complex, class II, DO beta
3113 HLA-DPA1; major histocompatibility complex, class II, DP alpha 1
3115 HLA-DPB1; major histocompatibility complex, class II, DP beta 1
3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1
3118 HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2
3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1
3122 HLA-DRA; major histocompatibility complex, class II, DR alpha
3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1
3125 HLA-DRB3; major histocompatibility complex, class II, DR beta 3
3126 HLA-DRB4; major histocompatibility complex, class II, DR beta 4
3127 HLA-DRB5; major histocompatibility complex, class II, DR beta 5
3105 HLA-A; major histocompatibility complex, class I, A
3106 HLA-B; major histocompatibility complex, class I, B
3107 HLA-C; major histocompatibility complex, class I, C
3134 HLA-F; major histocompatibility complex, class I, F
3135 HLA-G; major histocompatibility complex, class I, G
3133 HLA-E; major histocompatibility complex, class I, E
941 CD80; CD80 molecule
942 CD86; CD86 molecule
940 CD28; CD28 molecule
5551 PRF1; perforin 1
3683 ITGAL; integrin subunit alpha L
3689 ITGB2; integrin subunit beta 2
3383 ICAM1; intercellular adhesion molecule 1
102723407 IGH; immunoglobulin heavy variable 4-38-2-like
|
K06788 CXADR; coxsackievirus and adenovirus receptor
K04006 DAF; decay accelerating factor
K05703 FYN; tyrosine-protein kinase Fyn [EC:2.7.10.2]
K06278 CAV1; caveolin 1
K06619 ABL1; abelson tyrosine-protein kinase 1 [EC:2.7.10.2]
K08887 ABL2; abelson tyrosine-protein kinase 2 [EC:2.7.10.2]
K04392 RAC1; Ras-related C3 botulinum toxin substrate 1
K07860 RAC2; Ras-related C3 botulinum toxin substrate 2
K07861 RAC3; Ras-related C3 botulinum toxin substrate 3
K12563 SGCD; delta-sarcoglycan
K12564 SGCG; gamma-sarcoglycan
K12565 SGCA; alpha-sarcoglycan
K12566 SGCB; beta-sarcoglycan
K05637 LAMA1_2; laminin, alpha 1/2
K05637 LAMA1_2; laminin, alpha 1/2
K06265 DAG1; dystroglycan 1
K10366 DMD; dystrophin
K05692 ACTB_G1; actin beta/gamma 1
K05692 ACTB_G1; actin beta/gamma 1
K03260 EIF4G; translation initiation factor 4G
K03260 EIF4G; translation initiation factor 4G
K03260 EIF4G; translation initiation factor 4G
K04503 CCND1; G1/S-specific cyclin-D1
K04398 CASP8; caspase 8 [EC:3.4.22.61]
K04726 BID; BH3 interacting domain death agonist
K08738 CYC; cytochrome c
K04399 CASP9; caspase 9 [EC:3.4.22.62]
K02187 CASP3; caspase 3 [EC:3.4.22.56]
K17751 MYH6_7; myosin heavy chain 6/7
K17751 MYH6_7; myosin heavy chain 6/7
K03161 TNFSF5; tumor necrosis factor ligand superfamily member 5
K03160 TNFRSF5; tumor necrosis factor receptor superfamily member 5
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K05412 CD80; CD80 antigen
K05413 CD86; CD86 antigen
K06470 CD28; CD28 antigen
K07818 PRF1; perforin 1
K05718 ITGAL; integrin alpha L
K06464 ITGB2; integrin beta 2
K06490 ICAM1; intercellular adhesion molecule 1
K06856 IGH; immunoglobulin heavy chain
|
|
|
09167 Endocrine and metabolic disease
|
04930 Type II diabetes mellitus [PATH:hsa04930]
|
04940 Type I diabetes mellitus [PATH:hsa04940]
|
3630 INS; insulin
2571 GAD1; glutamate decarboxylase 1
2572 GAD2; glutamate decarboxylase 2
5798 PTPRN; protein tyrosine phosphatase receptor type N
5799 PTPRN2; protein tyrosine phosphatase receptor type N2
1363 CPE; carboxypeptidase E
3329 HSPD1; heat shock protein family D (Hsp60) member 1
3382 ICA1; islet cell autoantigen 1
3108 HLA-DMA; major histocompatibility complex, class II, DM alpha
3109 HLA-DMB; major histocompatibility complex, class II, DM beta
3111 HLA-DOA; major histocompatibility complex, class II, DO alpha
3112 HLA-DOB; major histocompatibility complex, class II, DO beta
3113 HLA-DPA1; major histocompatibility complex, class II, DP alpha 1
3115 HLA-DPB1; major histocompatibility complex, class II, DP beta 1
3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1
3118 HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2
3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1
3122 HLA-DRA; major histocompatibility complex, class II, DR alpha
3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1
3125 HLA-DRB3; major histocompatibility complex, class II, DR beta 3
3126 HLA-DRB4; major histocompatibility complex, class II, DR beta 4
3127 HLA-DRB5; major histocompatibility complex, class II, DR beta 5
941 CD80; CD80 molecule
942 CD86; CD86 molecule
940 CD28; CD28 molecule
3592 IL12A; interleukin 12A
3593 IL12B; interleukin 12B
3558 IL2; interleukin 2
3458 IFNG; interferon gamma
3105 HLA-A; major histocompatibility complex, class I, A
3106 HLA-B; major histocompatibility complex, class I, B
3107 HLA-C; major histocompatibility complex, class I, C
3134 HLA-F; major histocompatibility complex, class I, F
3135 HLA-G; major histocompatibility complex, class I, G
3133 HLA-E; major histocompatibility complex, class I, E
356 FASLG; Fas ligand
355 FAS; Fas cell surface death receptor
5551 PRF1; perforin 1
3002 GZMB; granzyme B
4049 LTA; lymphotoxin alpha
7124 TNF; tumor necrosis factor
3552 IL1A; interleukin 1 alpha
3553 IL1B; interleukin 1 beta
|
K04526 INS; insulin
K01580 E4.1.1.15; glutamate decarboxylase [EC:4.1.1.15]
K01580 E4.1.1.15; glutamate decarboxylase [EC:4.1.1.15]
K07817 PTPRN; receptor-type tyrosine-protein phosphatase N [EC:3.1.3.48]
K07817 PTPRN; receptor-type tyrosine-protein phosphatase N [EC:3.1.3.48]
K01294 CPE; carboxypeptidase E [EC:3.4.17.10]
K04077 groEL; chaperonin GroEL
K19863 ICA1; islet cell auto antigen 1
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K05412 CD80; CD80 antigen
K05413 CD86; CD86 antigen
K06470 CD28; CD28 antigen
K05406 IL12A; interleukin 12A
K05425 IL12B; interleukin 12B
K05429 IL2; interleukin 2
K04687 IFNG; interferon gamma
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K06751 MHC1; MHC class I antigen
K04389 TNFSF6; tumor necrosis factor ligand superfamily member 6
K04390 TNFRSF6; tumor necrosis factor receptor superfamily member 6
K07818 PRF1; perforin 1
K01353 GZMB; granzyme B [EC:3.4.21.79]
K05468 LTA; lymphotoxin alpha (TNF superfamily, member 1)
K03156 TNF; tumor necrosis factor superfamily, member 2
K04383 IL1A; interleukin 1 alpha
K04519 IL1B; interleukin 1 beta
|
04950 Maturity onset diabetes of the young [PATH:hsa04950]
|
04932 Non-alcoholic fatty liver disease [PATH:hsa04932]
|
04931 Insulin resistance [PATH:hsa04931]
|
04933 AGE-RAGE signaling pathway in diabetic complications [PATH:hsa04933]
|
04934 Cushing syndrome [PATH:hsa04934]
|
|
|
09171 Infectious disease: bacterial
|
|
|
09172 Infectious disease: viral
|
|
|
09174 Infectious disease: parasitic
|
|
|
09175 Drug resistance: antimicrobial
|
|
|
09176 Drug resistance: antineoplastic
|
|
|
09180 Brite Hierarchies
|
|
|
09190 Not Included in Pathway or Brite
|
KEGG Orthology (KO) - Homo sapiens (human)